a few people working at a table

Press Releases

Ladenburg Thalmann Acts as Sole Placement Agent for Calidi Biotherapeutics, Inc. in their $6.1 Million Public Offering

Transaction Information Calidi Biotherapeutics, Inc. (NYSE American: CLDI or "Calidi") announced the closing of its...

Ladenburg Acts as Exclusive Placement Agent in $6.5 Million Financing for Biodexa Pharmaceuticals

Ladenburg also acts as Exclusive Advisor for In-License of Phase 3 Ready Asset, eRapa for Familial Adenomatous...

Ladenburg Acts as Exclusive Placement Agent for Intelligent Bio Solutions in their $10.1 Million Private Placement

Transaction Information Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company") announced the...

Ladenburg Acts as Exclusive Placement Agent in the $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules for Palisade Bio, Inc.

Transaction Information Palisade Bio, Inc. (Nasdaq: PALI) announced that it has closed its private placement with...

Ladenburg Acts as Exclusive Placement Agent in the $1.77 Million Warrant Exercise Transaction for Intelligent Bio Solutions Inc.

Transaction Information Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company") announced an...

Ladenburg Acts as Sole Book-Running Manager in $4.172 Million Underwritten Public Offering for Peraso, Inc.

Transaction Information Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company") announced the closing of its...

Ladenburg Thalmann Acts as Placement Agent for Immunic, Inc in a Private Placement of up to $240 Million

Transaction Information Immunic, Inc. (Nasdaq: IMUX) announced it has entered into a securities purchase agreement...

Ladenburg Acts as Exclusive Placement Agent in the $2.5 Million Warrant Exercise Transaction for Palisade Bio, Inc.

Transaction Information Palisade Bio, Inc. (Nasdaq: PALI) ("Palisade" or the "Company") announced an agreement...

Ladenburg Thalmann Acts as Sole Book-Running Manager in $6 Million Underwritten Public Offering for Biodexa Pharmaceuticals PLC

Transaction Information Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) announced the closing of an underwritten public...